|
Aptus Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
88.84 Cr.
|
P/BV
|
10.07
|
Book Value (Rs.)
|
12.87
|
|
52 Week High/Low (Rs.)
|
132/81
|
FV/ML
|
10/2000
|
P/E(X)
|
28.67
|
|
Bookclosure
|
|
EPS (Rs.)
|
4.52
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| | | | |
| INCOME | | | |
| Revenue From Operations [Net] | 24.56 | 17.86 | 13.90 |
| Total Operating Revenues | 24.56 | 17.86 | 13.90 |
| | | | |
| Other Income | 0.08 | 0.03 | 0.00 |
| Total Revenue | 24.64 | 17.88 | 13.90 |
| | | | |
| EXPENSES | | | |
| Purchase Of Stock-In Trade | 12.67 | 7.95 | 5.67 |
| Operating And Direct Expenses | 1.99 | 2.74 | 3.26 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -3.63 | -1.13 | -0.90 |
| Employee Benefit Expenses | 3.57 | 2.55 | 1.79 |
| Finance Costs | 0.47 | 0.24 | 0.14 |
| Depreciation And Amortisation Expenses | 0.27 | 0.21 | 0.18 |
| Other Expenses | 5.11 | 4.20 | 3.46 |
| Total Expenses | 20.44 | 16.76 | 13.60 |
| | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 4.20 | 1.12 | 0.30 |
| | | | |
| Profit/Loss Before Tax | 4.20 | 1.12 | 0.30 |
| | | | |
| Tax Expenses-Continued Operations | | | |
| Current Tax | 1.11 | 0.34 | 0.12 |
| Deferred Tax | -0.02 | -0.02 | -0.02 |
| Total Tax Expenses | 1.10 | 0.32 | 0.10 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 3.10 | 0.80 | 0.19 |
| | | | |
| Profit/Loss From Continuing Operations | 3.10 | 0.80 | 0.19 |
| | | | |
| Profit/Loss For The Period | 3.10 | 0.80 | 0.19 |
| | | | |
| OTHER INFORMATION | | | |
| | | | |
| EARNINGS PER SHARE | | | |
| Basic EPS (Rs.) | 6.37 | 5.32 | 1.30 |
| Diluted EPS (Rs.) | 6.37 | 5.32 | 1.30 |
